Medical News

RSS

Bavarian Nordic' Annual Report 2009

Today Bavarian Nordic published the company's Annual Report 2009. The report is available on the company's website: www.bavarian-nordic.com

10 Mar 2010

Abortion holding up Democrats endgame on health overhaul

House Majority Leader Steny Hoyer "said Tuesday that the abortion fight 'has to be resolved.' The majority leader expressed confidence that the issue would be wrapped up, but he also cautioned reporters that he had not had any formal negotiations with Rep. Bart Stupak, the Michigan Democrat who authored the House abortion restrictions.

10 Mar 2010

States' legislative health initiatives stall

The Boston Globe: "A group of Massachusetts mayors, fed up with what they say is legislative inaction on skyrocketing municipal health care costs, has launched a ballot initiative for 2012 aimed at giving cities and towns more flexibility in reducing expensive benefits for employees, retirees, and elected officials" (Murphy, 3/10).

10 Mar 2010

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

10 Mar 2010

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Legislators need pork to make things happen, especially in an age when chronic obstruction has so weakened the legislative process that policy breakthroughs are almost impossible. This does not excuse all kinds of deal making, nor should we ignore that deals sometimes go too far (Julian E. Zelizer, 3/10).

10 Mar 2010

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

Integra LifeSciences Holdings Corporation announced today the release of the Integra™ Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing soft tissue irritation. The system provides an optimal balance of compression and stability by combining the Surfix® locking technology and dynamic compression.

10 Mar 2010

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.

10 Mar 2010

FDA clears Oculus Innovative Sciences' Microcyn Skin and Wound HydroGel

Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.

10 Mar 2010

Health Care REIT prices 3.00% Convertible Senior Notes due 2029

Health Care REIT, Inc. today announced the pricing of its offering of $342,394,000 aggregate principal amount of 3.00% Convertible Senior Notes due 2029.

10 Mar 2010

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

NeoPharm, Inc., announced today that it has filed an orphan drug application with the Office of Orphan Products Development of the United States Food and Drug Administration to have Orphan Drug Designation granted to IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis.

10 Mar 2010

Stason Pharmaceuticals to market Unilife's Unitract 1mL safety syringe in Japan, China and Taiwan

Unilife Corporation today announced that it has signed an exclusive five-year agreement with Stason Pharmaceuticals Inc, a U.S.-based pharmaceutical company, to market the Unitract™ 1mL safety syringe in Japan, China and Taiwan. Stason's Taiwan-based strategic alliance affiliate, Standard Chem. and Pharm. Co., LTD, will act as the primary distributor of the product within these designated territories.

10 Mar 2010

BioTime's fourth-quarter fiscal 2009 total quarterly revenue up 163%

BioTime, Inc. today reported financial results for the fourth quarter and fiscal year ended December 31, 2009 and provided an update on recent corporate developments.

10 Mar 2010

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies’ exclusive global agreement to develop and commercialize Hematide™, Affymax’s investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.

10 Mar 2010

$Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures$

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

10 Mar 2010

$Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures$

Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures

Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

10 Mar 2010

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

Accelr8 Technology Corporation today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis.

10 Mar 2010

ZixCorp renewes and expandes contract with Wake Forest University Baptist Medical Center

Zix Corporation, the only email encryption service designed with your most important relationships in mind, has renewed and expanded its contract with Wake Forest University Baptist Medical Center, a leading North Carolina health system.

10 Mar 2010

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

Smith & Nephew's Endoscopy Division today announced the launch of the BIORAPTOR™ Knotless Suture Anchor, a device used to repair a torn labrum in the hip and shoulder. The anchor is among products featured at the American Academy of Orthopaedic Surgeons annual meeting, which began today in New Orleans.

10 Mar 2010

Labeltronix completes registration to the ISO 9001:2008 standard

Labeltronix, a leading provider of printed labels, labeling systems, supplies and technical support, announces that it has successfully completed registration to the ISO 9001:2008 standard, an internationally recognized protocol for quality assurance.

10 Mar 2010

McGill University's Nurse Practitioner programs to be sponsored by Abbott

Today Abbott Laboratories announced it will sponsor McGill University's Nurse Practitioner programs launched by the McGill School of Nursing of the Faculty of Medicine. Over the last five years, the Nurse Practitioner programs have provided advanced training for registered nurses that enables them to assume additional responsibilities to provide enhanced patient care.

10 Mar 2010

Medical News

Bavarian Nordic' Annual Report 2009

Abortion holding up Democrats endgame on health overhaul

States' legislative health initiatives stall

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

FDA clears Oculus Innovative Sciences' Microcyn Skin and Wound HydroGel

Health Care REIT prices 3.00% Convertible Senior Notes due 2029

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

Stason Pharmaceuticals to market Unilife's Unitract 1mL safety syringe in Japan, China and Taiwan

BioTime's fourth-quarter fiscal 2009 total quarterly revenue up 163%

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

ZixCorp renewes and expandes contract with Wake Forest University Baptist Medical Center

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

Labeltronix completes registration to the ISO 9001:2008 standard

McGill University's Nurse Practitioner programs to be sponsored by Abbott

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News